Genomics

Dataset Information

0

IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in PANC-1 (total RNA)]

ABSTRACT: IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in PANC-1 (total RNA)]

PROVIDER: PRJNA612006 | ENA |

REPOSITORIES: ENA

Json Xml

Dataset's files

Source:
Action DRS
SRR11290614_1.fastq.gz Fastqsanger.gz
SRR11290614_2.fastq.gz Fastqsanger.gz
SRR11290615_1.fastq.gz Fastqsanger.gz
SRR11290615_2.fastq.gz Fastqsanger.gz
SRR11290616_1.fastq.gz Fastqsanger.gz
Items per page:
1 - 5 of 12

Similar Datasets

Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in PANC-1 (total RNA)]
2020-06-17 | GSE146805 | GEO
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [METTL KD in PANC-1 (polyA RNA)]
2020-06-17 | GSE146806 | GEO
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [E2F1-3 KD in PANC-1 (polyA RNA)]
2020-06-17 | GSE146804 | GEO
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in MV3 (total RNA)]
2020-06-17 | GSE146803 | GEO
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in HepG2 (polyA RNA)]
2020-06-17 | GSE146802 | GEO
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KD in A549 (polyA RNA)]
2020-06-17 | GSE146547 | GEO
Transcriptomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [IGF2BP1 KO in A-549 (polyA RNA)]
2020-06-17 | GSE146546 | GEO
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [METTL KD in PANC-1 (polyA RNA)]
| PRJNA612005 | ENA
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer
| PRJNA612000 | ENA
Genomics IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression hallmark in cancer [E2F1-3 KD in PANC-1 (polyA RNA)]
| PRJNA612007 | ENA